Large-scale testing (Phase 3)Ended earlyNCT01704690What this trial is testingCombination Treatment of S-1 With Paclitaxel in Advanced Esophageal CancerWho this might be right forEsophageal Cancer Peking University 4
Post-approval studies (Phase 4)UnknownNCT04269369What this trial is testingImplementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated PatientsWho this might be right forColon CancerStomach TumorAnal Tumor+2 more Jessa Hospital 250
Large-scale testing (Phase 3)UnknownNCT04370418What this trial is testingNeo-adjuvant Short Course Chemo-radiation Therapy in Locally Advanced Rectal Cancer PatientsWho this might be right forNeo-adjuvant Short Course Chemo-radiotherapy in Locally Advanced Cancer Rectum Assiut University 8
Large-scale testing (Phase 3)Study completedNCT00024427What this trial is testingTriacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic CancerWho this might be right forDrug/Agent Toxicity by Tissue/OrganPancreatic Cancer Wellstat Therapeutics 250
Testing effectiveness (Phase 2)Ended earlyNCT00036517What this trial is testingSafety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal CancerWho this might be right forColorectal NeoplasmsDiarrhea PhytoCeutica 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06258525What this trial is testingSAMe in Prevention of Oxaliplatin-associated Liver InjuryWho this might be right forColorectal CancerLiver MetastasesLiver Metastasis Colon Cancer+4 more Cedars-Sinai Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT06782022What this trial is testingDPD Guided 5-FU Precision Treatment in Gastro-intestinal Cancer PatientsWho this might be right forGastrointestinal Cancers Jan Gerard Maring 80
Testing effectiveness (Phase 2)Study completedNCT00721513What this trial is testingDocetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerWho this might be right forHead and Neck Cancer Wake Forest University Health Sciences 20
Testing effectiveness (Phase 2)Ended earlyNCT04894123What this trial is testingCardiovascular Events From Trifluridine/Tipiracil +/- Oxaliplatin in Colorectal/Oesogastric Adenocarcinoma PatientsWho this might be right forColorectal AdenocarcinomaOesogastric GERCOR - Multidisciplinary Oncology Cooperative Group 1
Not applicableApproved For MarketingNCT01432301What this trial is testingUridine Triacetate as Antidote for Patients at Excess Risk of 5-FU Toxicity Due to Overdosage or Impaired EliminationWho this might be right forToxicity Due to Chemotherapy Wellstat Therapeutics
Testing effectiveness (Phase 2)Study completedNCT00001165What this trial is testingCombination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the PancreasWho this might be right forIslet Cell AdenomaNeoplasm MetastasisZollinger Ellison Syndrome National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 999
Testing effectiveness (Phase 2)Ended earlyNCT00568971What this trial is testingStudy of Weekly DCF to Treat Advanced Gastric CancerWho this might be right forGastric Cancer Fudan University 40
Testing effectiveness (Phase 2)Study completedNCT00767377What this trial is testingContinuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGCWho this might be right forGastric Cancer Fudan University 163
Not applicableStudy completedNCT02055560What this trial is testingRetrospective Evaluation of 5-FU Exposure Optimization in CRC PatientsWho this might be right forMetastatic Colorectal CancerAdjuvant Colorectal Cancer5-FU Containing Therapy Regimens Saladax Biomedical, Inc. 146
Post-approval studies (Phase 4)Study completedNCT01641458What this trial is testingPharmacology-driven Dosing of Fluoropyrimidines in Cancer PatientsWho this might be right forColorectal Cancer Cantonal Hospital of St. Gallen 37
Not applicableUnknownNCT00131599What this trial is testingThymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon CancerWho this might be right forColon Cancer AHS Cancer Control Alberta 104
Not applicableStudy completedNCT04042298What this trial is testingMicrovascular Function in Patients Undergoing 5-Fluorouracil ChemotherapyWho this might be right forGastrointestinal CancerHead and Neck CancerBreast Cancer+2 more Kansas State University 62
Testing effectiveness (Phase 2)Study completedNCT01181401What this trial is testingInductionChemo-Radio-Antibody-TreatmentWho this might be right forSquamous Cell Carcinoma of the HeadSquamous Cell Carcinoma of the Neck Charite University, Berlin, Germany 94
Not applicableStudy completedNCT03486340What this trial is testingPrevention of Chest Pain in Chemo-treated Cancer PatientsWho this might be right forSolid Carcinoma5-Fluorouracil ToxicityCardiotoxicity+4 more Vejle Hospital 218
Testing effectiveness (Phase 2)Ended earlyNCT00551759What this trial is testingChemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction CancerWho this might be right forEsophageal Cancer Eastern Cooperative Oncology Group 22